| UniProt ID | DNM3A_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y6K1 | |
| Protein Name | DNA (cytosine-5)-methyltransferase 3A | |
| Gene Name | DNMT3A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 912 | |
| Subcellular Localization | Nucleus . Cytoplasm . Accumulates in the major satellite repeats at pericentric heterochromatin.. | |
| Protein Description | Required for genome-wide de novo methylation and is essential for the establishment of DNA methylation patterns during development. DNA methylation is coordinated with methylation of histones. It modifies DNA in a non-processive manner and also methylates non-CpG sites. May preferentially methylate DNA linker between 2 nucleosomal cores and is inhibited by histone H1. Plays a role in paternal and maternal imprinting. Required for methylation of most imprinted loci in germ cells. Acts as a transcriptional corepressor for ZBTB18. Recruited to trimethylated 'Lys-36' of histone H3 (H3K36me3) sites. Can actively repress transcription through the recruitment of HDAC activity.. | |
| Protein Sequence | MPAMPSSGPGDTSSSAAEREEDRKDGEEQEEPRGKEERQEPSTTARKVGRPGRKRKHPPVESGDTPKDPAVISKSPSMAQDSGASELLPNGDLEKRSEPQPEEGSPAGGQKGGAPAEGEGAAETLPEASRAVENGCCTPKEGRGAPAEAGKEQKETNIESMKMEGSRGRLRGGLGWESSLRQRPMPRLTFQAGDPYYISKRKRDEWLARWKREAEKKAKVIAGMNAVEENQGPGESQKVEEASPPAVQQPTDPASPTVATTPEPVGSDAGDKNATKAGDDEPEYEDGRGFGIGELVWGKLRGFSWWPGRIVSWWMTGRSRAAEGTRWVMWFGDGKFSVVCVEKLMPLSSFCSAFHQATYNKQPMYRKAIYEVLQVASSRAGKLFPVCHDSDESDTAKAVEVQNKPMIEWALGGFQPSGPKGLEPPEEEKNPYKEVYTDMWVEPEAAAYAPPPPAKKPRKSTAEKPKVKEIIDERTRERLVYEVRQKCRNIEDICISCGSLNVTLEHPLFVGGMCQNCKNCFLECAYQYDDDGYQSYCTICCGGREVLMCGNNNCCRCFCVECVDLLVGPGAAQAAIKEDPWNCYMCGHKGTYGLLRRREDWPSRLQMFFANNHDQEFDPPKVYPPVPAEKRKPIRVLSLFDGIATGLLVLKDLGIQVDRYIASEVCEDSITVGMVRHQGKIMYVGDVRSVTQKHIQEWGPFDLVIGGSPCNDLSIVNPARKGLYEGTGRLFFEFYRLLHDARPKEGDDRPFFWLFENVVAMGVSDKRDISRFLESNPVMIDAKEVSAAHRARYFWGNLPGMNRPLASTVNDKLELQECLEHGRIAKFSKVRTITTRSNSIKQGKDQHFPVFMNEKEDILWCTEMERVFGFPVHYTDVSNMSRLARQRLLGRSWSVPVIRHLFAPLKEYFACV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MPAMPSSGPGDTS --CCCCCCCCCCCCC | 34.54 | 23401153 | |
| 7 | Phosphorylation | -MPAMPSSGPGDTSS -CCCCCCCCCCCCCC | 43.04 | 23401153 | |
| 12 | Phosphorylation | PSSGPGDTSSSAAER CCCCCCCCCCCHHHH | 36.10 | 23401153 | |
| 13 | Phosphorylation | SSGPGDTSSSAAERE CCCCCCCCCCHHHHH | 27.34 | 23401153 | |
| 14 | Phosphorylation | SGPGDTSSSAAEREE CCCCCCCCCHHHHHH | 26.53 | 28060719 | |
| 15 | Phosphorylation | GPGDTSSSAAEREED CCCCCCCCHHHHHHH | 31.13 | 27732954 | |
| 23 | Methylation | AAEREEDRKDGEEQE HHHHHHHHCCCCCCC | 42.09 | - | |
| 62 | Phosphorylation | RKHPPVESGDTPKDP CCCCCCCCCCCCCCC | 42.05 | 28555341 | |
| 65 | Phosphorylation | PPVESGDTPKDPAVI CCCCCCCCCCCCHHH | 35.45 | 25159151 | |
| 75 | Phosphorylation | DPAVISKSPSMAQDS CCHHHCCCHHHHCCC | 18.54 | 30266825 | |
| 77 | Phosphorylation | AVISKSPSMAQDSGA HHHCCCHHHHCCCCC | 33.56 | 30266825 | |
| 82 | Phosphorylation | SPSMAQDSGASELLP CHHHHCCCCCCCCCC | 24.95 | 25850435 | |
| 85 | Phosphorylation | MAQDSGASELLPNGD HHCCCCCCCCCCCCC | 32.10 | 25850435 | |
| 97 | Phosphorylation | NGDLEKRSEPQPEEG CCCHHHCCCCCCCCC | 65.77 | 23403867 | |
| 102 | Phosphorylation | KRSEPQPEEGSPAGG HCCCCCCCCCCCCCC | 70.51 | 18669648 | |
| 105 | Phosphorylation | EPQPEEGSPAGGQKG CCCCCCCCCCCCCCC | 18.17 | 29255136 | |
| 124 | Phosphorylation | EGEGAAETLPEASRA CCCCHHHHCHHHHHH | 42.77 | 26074081 | |
| 138 | Phosphorylation | AVENGCCTPKEGRGA HHHCCCCCCCCCCCC | 41.28 | 25850435 | |
| 144 (in isoform 2) | Ubiquitination | - | 46.93 | 21890473 | |
| 156 | Phosphorylation | AGKEQKETNIESMKM CCHHHHHHCHHHEEE | 48.83 | - | |
| 162 | Sumoylation | ETNIESMKMEGSRGR HHCHHHEEEECCCCC | 42.98 | 28112733 | |
| 171 | Methylation | EGSRGRLRGGLGWES ECCCCCCCCCCCCCH | 35.45 | - | |
| 178 | Phosphorylation | RGGLGWESSLRQRPM CCCCCCCHHHCCCCC | 28.32 | 28555341 | |
| 179 | Phosphorylation | GGLGWESSLRQRPMP CCCCCCHHHCCCCCC | 18.96 | - | |
| 199 | Phosphorylation | AGDPYYISKRKRDEW CCCCEEECCCCHHHH | 15.41 | 27251275 | |
| 200 | Ubiquitination | GDPYYISKRKRDEWL CCCEEECCCCHHHHH | 52.99 | 21890473 | |
| 200 (in isoform 1) | Ubiquitination | - | 52.99 | 21890473 | |
| 236 | Phosphorylation | ENQGPGESQKVEEAS HCCCCCCCCCCCCCC | 41.01 | 21406692 | |
| 243 | Phosphorylation | SQKVEEASPPAVQQP CCCCCCCCCCCCCCC | 34.39 | 25159151 | |
| 251 | Phosphorylation | PPAVQQPTDPASPTV CCCCCCCCCCCCCCC | 50.72 | 25159151 | |
| 255 | Phosphorylation | QQPTDPASPTVATTP CCCCCCCCCCCCCCC | 26.88 | 23401153 | |
| 257 | Phosphorylation | PTDPASPTVATTPEP CCCCCCCCCCCCCCC | 21.93 | 25159151 | |
| 260 | Phosphorylation | PASPTVATTPEPVGS CCCCCCCCCCCCCCC | 38.25 | 25159151 | |
| 261 | Phosphorylation | ASPTVATTPEPVGSD CCCCCCCCCCCCCCC | 18.86 | 25159151 | |
| 267 | Phosphorylation | TTPEPVGSDAGDKNA CCCCCCCCCCCCCCC | 25.23 | 30631047 | |
| 275 | Phosphorylation | DAGDKNATKAGDDEP CCCCCCCCCCCCCCC | 30.71 | 25841592 | |
| 276 | Ubiquitination | AGDKNATKAGDDEPE CCCCCCCCCCCCCCC | 48.22 | - | |
| 299 | Ubiquitination | IGELVWGKLRGFSWW HHHHHHHCCCCCCCC | 21.21 | - | |
| 367 (in isoform 1) | Ubiquitination | - | 22.96 | 21890473 | |
| 367 | Ubiquitination | NKQPMYRKAIYEVLQ CCCCHHHHHHHHHHH | 22.96 | 21890473 | |
| 377 | Phosphorylation | YEVLQVASSRAGKLF HHHHHHHHHHCCCEE | 22.85 | - | |
| 382 | Ubiquitination | VASSRAGKLFPVCHD HHHHHCCCEECCCCC | 46.07 | - | |
| 390 | Phosphorylation | LFPVCHDSDESDTAK EECCCCCCCCCCCCH | 21.44 | 21406692 | |
| 393 | Phosphorylation | VCHDSDESDTAKAVE CCCCCCCCCCCHHEE | 45.30 | 21406692 | |
| 395 | Phosphorylation | HDSDESDTAKAVEVQ CCCCCCCCCHHEEEC | 39.06 | 21406692 | |
| 420 | Ubiquitination | GFQPSGPKGLEPPEE CCCCCCCCCCCCCHH | 78.60 | - | |
| 437 | Phosphorylation | NPYKEVYTDMWVEPE CCCCEEECCCCCCHH | 25.26 | 27642862 | |
| 448 | Phosphorylation | VEPEAAAYAPPPPAK CCHHHHHCCCCCCCC | 18.21 | 27642862 | |
| 468 | Sumoylation | TAEKPKVKEIIDERT CCCCCCHHHHHCHHH | 49.69 | - | |
| 468 | Sumoylation | TAEKPKVKEIIDERT CCCCCCHHHHHCHHH | 49.69 | - | |
| 638 | Phosphorylation | RKPIRVLSLFDGIAT CCCCEEEECCCCCHH | 24.92 | - | |
| 645 | Phosphorylation | SLFDGIATGLLVLKD ECCCCCHHHHHHHHH | 26.83 | - | |
| 721 | Ubiquitination | SIVNPARKGLYEGTG CCCCCCCCCCCCCCC | 56.21 | - | |
| 783 | Ubiquitination | NPVMIDAKEVSAAHR CCEEEEHHHHHHHHH | 55.70 | - | |
| 812 | Ubiquitination | LASTVNDKLELQECL CHHHHCHHHHHHHHH | 38.36 | - | |
| 839 | Phosphorylation | TITTRSNSIKQGKDQ EEECCCCCHHCCCCC | 32.20 | 24719451 | |
| 844 | Ubiquitination | SNSIKQGKDQHFPVF CCCHHCCCCCCCCEE | 52.28 | - | |
| 882 | Methylation | TDVSNMSRLARQRLL CCHHHHHHHHHHHHH | 22.92 | - | |
| 894 | Phosphorylation | RLLGRSWSVPVIRHL HHHCCCCHHHHHHHH | 20.14 | 27251275 | |
| 906 | Ubiquitination | RHLFAPLKEYFACV- HHHHHHHHHHHCCC- | 49.67 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DNM3A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNM3A_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615879 | Tatton-Brown-Rahman syndrome (TBRS) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105, AND MASSSPECTROMETRY. | |